​

Nexalin Ownership | Who Owns Nexalin?

OverviewRevenueFinancialsChart

Nexalin Ownership Summary

Nexalin is owned by 2.13% institutional investors, 13.78% insiders, and 84.09% retail investors. Vanguard group is the largest institutional shareholder, holding 1.00% of NXL shares.

NXL Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockNexalin2.13%13.78%84.09%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryMedical Device Stocks37.54%10.61%51.85%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group177.92K1.00%$99.28K
Geode capital management150.27K0.84%$83.85K
Morgan stanley59.80K0.80%$101.07K
Cvi55.46K0.75%$93.73K
Renaissance122.10K0.69%$68.13K
State street32.30K0.21%$29.63K
Jane street group35.02K0.20%$19.54K
Northern trust24.10K0.15%$22.11K
Kovack advisors23.32K0.13%$6.57K
Ubs group15.90K0.09%$8.87K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Cvi55.46K0.08%$93.73K
Xtx topco11.91K0.00%$10.92K
Kovack advisors23.32K0.00%$6.57K
Atria wealth solutions10.35K0.00%$10.22K
Renaissance122.10K0.00%$68.13K
Ifp advisors---
Tower research capital llc (trc)1.43K-$1.31K
Rockefeller capital management1.50K-$1.38K
Myda advisors---
Susquehanna group, llp---

Top Buyers

HolderShares% AssetsChange
Renaissance122.10K0.00%66.40K
Morgan stanley59.80K-59.80K
Cvi55.46K0.08%55.46K
Geode capital management150.27K-28.45K
Ubs group15.90K-15.46K

Top Sellers

HolderShares% AssetsChange
Myda advisors---150.00K
Susquehanna group, llp---42.38K
Virtu financial---23.45K
Drive wealth management---15.00K
Cetera investment advisers---14.00K

New Positions

HolderShares% AssetsChangeValue
Morgan stanley59.80K-59.80K$101.07K
Cvi55.46K0.08%55.46K$93.73K
Lpl financial10.48K-10.48K$5.85K
Rockefeller capital management1.50K-1.50K$1.38K
Bank of america corp /de/46.00-46.00$78.00

Sold Out

HolderChange
Citigroup-88.00
Spire wealth management-300.00
Stone house investment management-357.00
Wells fargo & company/mn-600.00
Princeton global asset management-1.00K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20256-70.00%378,903-45.53%210.87%5-37.50%--100.00%
Sep 30, 20254-78.95%187,720-85.26%11.82%2-81.82%--
Jun 30, 20252123.53%1,314,236230.95%893.89%1385.71%--100.00%
Mar 31, 202517-5.56%397,1166.95%225.47%8-50.00%3200.00%
Dec 31, 20241721.43%339,026-20.83%320.05%1566.67%1-66.67%

Recent Insider Transactions

DateNameRoleActivityValue
Sep 10, 2025Elson Marilyn-Sell$96.07K
Mar 12, 2025Shelton Carolyn Hamby Sr. VP - Quality, RegulatoryBuy$13.20K
Feb 04, 2025Owens David Chief Medical OfficerBuy$3.10K
Feb 04, 2025Owens David Chief Medical OfficerBuy$2.98K
Nov 02, 2024Kazden Alan-Buy$246.75K

Insider Transactions Trends

DateBuySell
2026 Q3--
2025 Q3--
2025 Q16-
2024 Q42-
2024 Q31-

NXL Ownership FAQ

Who Owns Nexalin?

Nexalin shareholders are primarily institutional investors at 2.13%, followed by 13.78% insiders and 84.09% retail investors. The average institutional ownership in Nexalin's industry, Medical Device Stocks, is 37.54%, which Nexalin falls below.

Who owns the most shares of Nexalin?

Nexalin’s largest shareholders are Vanguard group (177.92K shares, 1.00%), Geode capital management (150.27K shares, 0.84%), and Morgan stanley (59.8K shares, 0.80%). Together, they hold 2.65% of Nexalin’s total shares outstanding.

Does Blackrock own Nexalin?

BlackRock is not among the top 10 institutional shareholders of Nexalin.

Who is Nexalin’s biggest shareholder by percentage of total assets invested?

Cvi is Nexalin’s biggest shareholder by percentage of total assets invested, with 0.08% of its assets in 55.46K Nexalin shares, valued at 93.73K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools